Literature DB >> 2988328

A practical cytopathic effect/dye-uptake interferon assay for routine use in the clinical laboratory.

S Yousefi, M R Escobar, C W Gouldin.   

Abstract

The clinical value of interferon (IFN) level determinations has been demonstrated, but a practical assay procedure for routine use in the diagnostic laboratory has not been available. The authors examined the susceptibility of five cell lines (WISH, HEp-2, Vero, A549, and WI-26VA4) to vesicular stomatitis virus (VSV) and encephalomyocarditis virus (EMCV), and compared the response of these cells to the inhibitory activity of IFN-alpha and IFN-gamma for the respective viral cytopathic effect (CPE). The WISH-EMCV system was the most sensitive for IFN-alpha, and was approximately as sensitive as the HEp-2-VSV system for IFN-gamma. WISH cells were found to be significantly more sensitive for both IFN-alpha and IFN-gamma when EMCV, instead of VSV, was used (P less than 0.001). Therefore, the latter system served as the basis for developing a CPE dye-uptake procedure that was found to be considerably more rapid but slightly less sensitive than the conventional technic. However, both procedures were equally reproducible and should be suitable for automation.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2988328     DOI: 10.1093/ajcp/83.6.735

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  7 in total

1.  The toll-like receptor 3-mediated antiviral response is important for protection against poliovirus infection in poliovirus receptor transgenic mice.

Authors:  Yuko Abe; Ken Fujii; Noriyo Nagata; Osamu Takeuchi; Shizuo Akira; Hiroyuki Oshiumi; Misako Matsumoto; Tsukasa Seya; Satoshi Koike
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

2.  Disturbance of tumor necrosis factor alpha-mediated beta interferon signaling in cervical carcinoma cells.

Authors:  Anastasia Bachmann; Brigitte Hanke; Rainer Zawatzky; Ubaldo Soto; Jan van Riggelen; Harald zur Hausen; Frank Rösl
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

3.  Role of the alpha/beta interferon response in the acquisition of susceptibility to poliovirus by kidney cells in culture.

Authors:  Tomoki Yoshikawa; Takuya Iwasaki; Miki Ida-Hosonuma; Mitsutoshi Yoneyama; Takashi Fujita; Hitoshi Horie; Miwako Miyazawa; Shinobu Abe; Bunsiti Simizu; Satoshi Koike
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

4.  Antiviral activity of limitin against encephalomyocarditis virus, herpes simplex virus, and mouse hepatitis virus: diverse requirements by limitin and alpha interferon for interferon regulatory factor 1.

Authors:  Shin-Ichiro Kawamoto; Kenji Oritani; Hideo Asada; Isao Takahashi; Jun Ishikawa; Hitoshi Yoshida; Masahide Yamada; Naoko Ishida; Hidetoshi Ujiie; Hiroaki Masaie; Yoshiaki Tomiyama; Yuji Matsuzawa
Journal:  J Virol       Date:  2003-09       Impact factor: 5.103

5.  Treatment of chronic hepatitis C with high-dose interferon alpha-2b. A multicenter study.

Authors:  S Iino; K Hino; T Kuroki; H Suzuki; S Yamamoto
Journal:  Dig Dis Sci       Date:  1993-04       Impact factor: 3.199

6.  Differential antiviral response of endothelial cells after infection with pathogenic and nonpathogenic hantaviruses.

Authors:  Annette A Kraus; Martin J Raftery; Thomas Giese; Rainer Ulrich; Rainer Zawatzky; Stefan Hippenstiel; Norbert Suttorp; Detlev H Krüger; Günther Schönrich
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

7.  Process development for production of recombinant human interferon-gamma expressed in Escherichia coli.

Authors:  R Khalilzadeh; S A Shojaosadati; N Maghsoudi; J Mohammadian-Mosaabadi; M R Mohammadi; A Bahrami; N Maleksabet; M A Nassiri-Khalilli; M Ebrahimi; H Naderimanesh
Journal:  J Ind Microbiol Biotechnol       Date:  2004-02-19       Impact factor: 3.346

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.